![]()
![]()
This program provides presentations by experts in the field of seasonal and pandemic influenza. All health care professionals require seasonally updated information on the epidemiology, diagnosis, management, and prevention of influenza. Preparation for flu season includes an understanding of current epidemiological trends, immunization efforts, and treatment options. This understanding will also aid in influenza pandemic preparedness in the event of an outbreak.
![]()
This activity is targeted to physicians and physician assistants.
![]()
- Identify patients at risk for seasonal influenza based on current epidemiological trends
- Review the medical challenges of an influenza pandemic based on historical facts and current research
- Implement programs that will improve the success of immunization programs in the practice setting by employing practices demonstrated to improve immunization rates
- Determine when to appropriately prescribe antiviral therapies for the prevention and treatment of influenza by utilizing knowledge of current data and expert recommendations
![]()
Michael L. Tapper, MD
CME Course Director
Clinical Professor of Medicine
New York University School of Medicine
Hospital Epidemiologist
Director, Division of Infectious Diseases
Lenox Hill Hospital
New York, NY
Arnold S. Monto, MD
Professor of Epidemiology
University of Michigan School of Public Health
Founding Director
University of Michigan
Bioterrorism Preparedness Initiative
Ann Arbor, Michigan
Gregory A. Poland, MD
Mary Lowell Leary Professor of Medicine
Mayo Clinic College of Medicine
Director, Mayo Vaccine Research Group
Mayo Clinic and Foundation
Rochester, Minnesota
John J. Treanor, MD
Professor of Medicine and of Microbiology and Immunology
University of Rochester Medical Center
Staff Physician
Strong Memorial Hospital
Rochester, New York
![]()
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of NYU Post-Graduate Medical School and the Lenox Hill Hospital. NYU Post-Graduate Medical School is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The NYU Post-Graduate Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.
For further information about this Internet CME activity, contact the NYU Post-Graduate Medical School at 212-263-5292.
Physician Assistants who complete this activity and pass the posttest will receive a Certificate of Participation.
![]()
The NYU Post-Graduate Medical School adheres to ACCME Essential Areas and Policies, including the Standards for Commercial Support regarding industry support of continuing medical education. In order to resolve any identified Conflicts of Interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, is made known below.
![]()
Michael L. Tapper, MD
- Dr.Tapper serves on the speakers bureaus of Gilead Sciences and Roche Laboratories.
Arnold S. Monto, MD
- Dr. Monto is a consultant for GlaxoSmithKline, Novartis, Roche Laboratories, and Solvay and holds a research grant from Sanofi Pasteur.
Gregory A. Poland, MD
- Dr. Poland holds research grants from Merck & Co., Novavax, and Protein Sciences. He is a consultant for Avianax, CSL Biotherapies, Dynavax, GlaxoSmithKline, Merck & Co., Novartis Vaccines, Novavax, and Powdermed.
John J. Treanor, MD
- Dr. Treanor is a consultant for Alphavax, Dynavax, and Toyoma Chemical; serves on the speakers bureaus of GlaxoSmithKline, Novartis, Novavax, and Powdermed; and is contracted to do research for Merck & Co., Protein Sciences, and Wyeth.
The independent reviewer of this activity has no real or apparent conflicts of interest to report.
![]()
Internet Activity
![]()
Windows
- Windows 2000, ME, XP, Vista
- IE 5.0 or later/Netscape 7/Mozilla 1.5/Opera 7/Firefox
- Flash 7 or later
Macintosh
- OS X
- Safari/Mozilla 1.5
- Flash 7 or later
Internet Connection
- Minimum connection of 56Kbps
![]()
For further information about the NYU School of Medicine privacy and confidentiality policy, click here: http://www.med.nyu.edu/contact/privacy.html
![]()
Unless otherwise noted, all documents accessed from this page are viewed as a precious resource of NYU and are Copyright, NYU Post-Graduate Medical School, all rights reserved. The content of Dr. Gregory Poland’s presentation is the copyrighted property of Mayo Foundation for Medical Education and Research or the original copyright holder.
![]()
The material presented in this activity is a direct capture of presentations made at the CME-certified satellite symposium at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that was held in Chicago, IL, on September 17, 2007. The opinions and data expressed in this activity are the responsibility of the presenters, and do not necessarily reflect the opinions of NYU Post-Graduate Medical School, Lenox Hill Hospital, the educational grant support providers or HealthMatters Communications. Please consult the appropriate package insert for full prescribing information on all drug therapies discussed.

